Marshall Wace North America’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $778K | Sell |
11,135
-1,828,378
| -99% | -$128M | ﹤0.01% | 968 |
|
|
2021
Q2 | $127M | Sell |
1,839,513
-84,474
| -4% | -$5.82M | 0.53% | 35 |
|
|
2021
Q1 | $124M | Buy |
1,923,987
+654,400
| +52% | +$42.3M | 0.51% | 36 |
|
|
2020
Q4 | $74M | Buy |
1,269,587
+1,233,746
| +3,442% | +$71.9M | 0.33% | 70 |
|
|
2020
Q3 | $2.27M | Sell |
35,841
-71,433
| -67% | -$4.51M | 0.01% | 554 |
|
|
2020
Q2 | $8.25M | Sell |
107,274
-69,844
| -39% | -$5.37M | 0.05% | 287 |
|
|
2020
Q1 | $13.2M | Sell |
177,118
-1,302,055
| -88% | -$97.3M | 0.1% | 193 |
|
|
2019
Q4 | $96.1M | Sell |
1,479,173
-2,397,842
| -62% | -$156M | 0.46% | 59 |
|
|
2019
Q3 | $246M | Buy |
3,877,015
+458,819
| +13% | +$29.1M | 1.4% | 8 |
|
|
2019
Q2 | $231M | Buy |
3,418,196
+2,559,972
| +298% | +$173M | 1.43% | 12 |
|
|
2019
Q1 | $55.8M | Sell |
858,224
-135,082
| -14% | -$8.78M | 0.39% | 76 |
|
|
2018
Q4 | $62.1M | Buy |
993,306
+86,386
| +10% | +$5.4M | 0.6% | 45 |
|
|
2018
Q3 | $70M | Buy |
+906,920
| New | +$70M | 0.48% | 54 |
|
|
2018
Q2 | – | Sell |
-20,058
| Closed | -$1.51M | – | 1492 |
|
|
2018
Q1 | $1.51M | Buy |
+20,058
| New | +$1.51M | 0.01% | 890 |
|
|
2017
Q4 | – | Sell |
-352,434
| Closed | -$28.5M | – | 1445 |
|
|
2017
Q3 | $28.5M | Sell |
352,434
-371,933
| -51% | -$30.1M | 0.18% | 152 |
|
|
2017
Q2 | $51.4M | Buy |
+724,367
| New | +$51.4M | 0.38% | 63 |
|
|
2013
Q4 | $7.56M | Buy |
+100,546
| New | +$7.56M | 0.16% | 147 |
|
|
2013
Q3 | – | Sell |
-16,961
| Closed | -$869K | – | 647 |
|
|
2013
Q2 | $869K | Buy |
+16,961
| New | +$869K | 0.07% | 243 |
|